Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

UAC to place 2 trillion shares of additional share issue

1/27/25 UNAC

Zaimer's debt collection agency started collecting debts

1/27/25 ZAYM

M.Video-Eldorado and Avito launched a joint smartphone buyback program

1/27/25 MVID

X5's revenue in 2024 to grow by 24%

1/27/25 X5

Seligdar's revenue in 2024 to grow by 8%

1/27/25 SELG

5Post launches cross-border delivery from China

1/27/25 X5

Lukoil's GCC in Stavropol will be built by the end of 2028 - beginning of 2029

1/24/25 LKOH

Eastern Exchange launches IPO infrastructure

1/24/25 MOEX

TGC-1 generation remained at the same level as last year

1/24/25 TGKA

LSR reported a decline in sales

1/24/25 LSRG